These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 16042890)

  • 1. [The heterogeneity of HCV quasi-species in the hypervariable region and its relationship to interferon therapy].
    Shi LL; Zhang L; Zhao GZ; Qiao GY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):523, 527. PubMed ID: 16042890
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects.
    Gaud U; Langer B; Petropoulou T; Thomas HC; Karayiannis P
    J Med Virol; 2003 Mar; 69(3):350-6. PubMed ID: 12526045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3.
    Yasmeen A; Hamid S; Granath FN; Lindström H; Elliott RM; Siddiqui AA; Persson MA
    J Viral Hepat; 2006 Feb; 13(2):87-95. PubMed ID: 16436126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.
    Sarrazin C; Mihm U; Herrmann E; Welsch C; Albrecht M; Sarrazin U; Traver S; Lengauer T; Zeuzem S
    J Infect Dis; 2005 Nov; 192(10):1710-9. PubMed ID: 16235168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection.
    Dai CY; Chuang WL; Chang WY; Chen SC; Lee LP; Hsieh MY; Hou NJ; Lin ZY; Huang JF; Hsieh MY; Wang LY; Yu ML
    J Infect Dis; 2006 Jan; 193(1):98-101. PubMed ID: 16323137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic hepatitis C: virologic and immunologic aspects].
    Moriya K; Koike K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):405-7. PubMed ID: 15359831
    [No Abstract]   [Full Text] [Related]  

  • 9. A chronic HCV positive hemodialysis patient with an unusual treatment complication.
    Mousa D; Altayeb A
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):282-6. PubMed ID: 17612040
    [No Abstract]   [Full Text] [Related]  

  • 10. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribavirin in chronic hepatitis C: past and future.
    Loustaud-Ratti V; Rousseau A; Marquet P; Denis F; Alain S
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):249-53. PubMed ID: 19344238
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
    Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
    J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of chronic hepatitis C and lichen planus--in two patients].
    Podányi B; Lengyel G; Kiss A; Szakonyi J; Schaff Z; Fehér J
    Orv Hetil; 2006 Mar; 147(12):547-50. PubMed ID: 16696378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid virologic response: a new milestone in the management of chronic hepatitis C.
    Poordad F; Reddy KR; Martin P
    Clin Infect Dis; 2008 Jan; 46(1):78-84. PubMed ID: 18171217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The evolution of the hypervariable region-1 of hepatitis C virus may predict liver fibrosis outcome after renal transplantation].
    Kamar N; Rostaing L; Selves J; Sandres-Saune K; Alric L; Durand D; Izopet J
    Nephrol Ther; 2005 Dec; 1(6):345-54. PubMed ID: 16895705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection.
    Chang LL; Cheng PN; Chen JS; Young KC
    Antiviral Res; 2007 Jul; 75(1):43-51. PubMed ID: 17194487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and therapeutic implications of hepatitis C virus compartmentalization.
    Di Liberto G; Roque-Afonso AM; Kara R; Ducoulombier D; Fallot G; Samuel D; Feray C
    Gastroenterology; 2006 Jul; 131(1):76-84. PubMed ID: 16831592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C.
    Gerotto M; Resti M; Dal Pero F; Migliorato I; Alberti A; Bortolotti F
    Infection; 2006 Apr; 34(2):62-5. PubMed ID: 16703294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different anti-HCV profiles of statins and their potential for combination therapy with interferon.
    Ikeda M; Abe K; Yamada M; Dansako H; Naka K; Kato N
    Hepatology; 2006 Jul; 44(1):117-25. PubMed ID: 16799963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structural and functional characterization of the hypervariable region in the HCV genome].
    Tanaka M; Yokosuka O; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):43-7. PubMed ID: 15359761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.